Primary immunosuppression of the first two recipients of hearts from ABO-incompatible donors and all recipients of hearts from ABO-compatible donors consisted of cyclosporine (Neoral, Novartis Canada; ...
Currently, patients who undergo blood-group (ABO)-incompatible, living donor liver transplantation tend to have poor outcomes. Given the lack of available ABO-compatible donors, however, there remains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback